Top Menu

KFF Analyzes Racial / Ethnic Disparities in COVID-19 Vaccinations

Ensuring equitable access to COVID-19 vaccines has been a top concern in the rollout process. According to a brief by the Kaiser Family Foundation (KFF), “National recommendations regarding vaccine distribution have emphasized the importance of ensuring equitable access, particularly for disproportionately affected groups, including people of color.” KFF identified some key barriers when it comes […]

Continue Reading 0
Xpectives.Health-logo-Square

Announcing Xpectives.Health – Conferences Focused on Understanding the Healthcare Consumer: Brought to you by DTC Perspectives

DTC Perspectives was organized in 2000 to focus on pharmaceutical marketing and in 2001 we launched The DTC National. In later years we organized conferences on Hospital Marketing, Multicultural Communications, OTC Marketing, and Disease Education. To better describe what we do, we are excited to refer to our conference series as Xpectives.Health. We see our […]

Continue Reading 0

Biden-Harris Administration to Re-Open Enrollment, Re-Examine Other Health Policies

Announced today, President Biden is set to sign two Executive Orders in his efforts to improve health care access and affordability to Americans. The Department of Health and Human Services (HHS) is expected to re-open a “Special Enrollment Period” this year to the Health Insurance Marketplace, from Feb. 15-May 15, allowing citizens in need of […]

Continue Reading 0
Samantha-Brown-Headshot-21

One-on-One with Mesmerize’s Samantha Brown

Sponsored Content Samantha Brown, Director of Business Development at Mesmerize, discussed the impacts COVID-19 has had on their business in a recent interview with Bob Ehrlich, Chairman & CEO of DTC Perspectives.  She shares how Mesmerize used this time to focus on expanding its point of care footprint and establishing new partnerships, while continuing to […]

Continue Reading 0
syringe-5873159_1920

US Gov’t in Talks to Purchase Additional 100 Million Doses Each of Pfizer-BioNTech & Moderna COVID-19 Vaccines

As part of President Biden’s National Action Strategy to combat the global pandemic, he has instructed his COVID-19 Response Coordinator to work with the Department of Health and Human Services (HHS) in securing an additional 100 million doses of each of the two COVID-19 vaccines that have been approved by the FDA from Pfizer-BioNTech and […]

Continue Reading 0
POC3-LOGO-LRG

PoC3 Updates Verification & Validation Guidance, Issues Certifications to Five Companies

The Point of Care Communication Council, PoC3, updated its official guidance regarding Verification and Validation. The 2021 guidance provides three major changes: the expansion of network audits to include a company’s asset management system’s internal control and procedures;the volume of campaign audits required for certification will be based on annual campaign volume (not individual campaign […]

Continue Reading 0
Bob Ehrlich

DTC Role in Covid Vaccine Success

This column is not about a DTC advertising campaign that already exists. Instead, it is about what should happen after the Covid-19 vaccine is approved. Unfortunately, too many Americans are skeptical of a vaccine.  Trump clearly showed that he was not medically accurate in many of his Covid related treatment statements. His vaccine program was […]

Continue Reading 0

Pfizer, BioNTech Announce Final Efficacy Analysis from Phase 3 Study of their COVID Vaccine Candidate

Early this morning, Pfizer and BioNTech issued a news release stating that the Phase 3 study of their MRNA-based COVID-19 vaccine met all primary efficacy endpoints. “Analysis of the data indicates a vaccine efficacy rate of 95% (p<0.0001) in participants without prior SARS-CoV-2 infection (first primary objective) and also in participants with and without prior […]

Continue Reading 0